Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
Monday, June 08, 2026The European Commission has approved Sarclisa isatuximab subcutaneous SC in combination with standardofcare regimens for the treatment of patients with multiple myeloma MM across all existing
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
Monday, June 08, 2026Amphista Therapeutics the Company or Amphista a leader in the discovery and development of next generation targeted protein degradation TPD medicines today announces that the US Food
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
Monday, June 08, 2026Alvotech NASDAQ ALVO ALVOSDB a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced that the US Food and Drug Administration
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration
Friday, June 05, 2026DaltonTx the intelligence backbone for modern drug discovery connecting AI human expertise and experimental data today announced the launch of Dalton its drug discovery platform
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Friday, June 05, 2026Amneal Pharmaceuticals Inc Amneal or the Company Nasdaq AMRX today announced that the US Food and Drug Administration FDA has approved the Companys romidepsin injection solution mg mL
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
Friday, June 05, 2026Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA today announced the launch of AHZANTIVE aflibercept a biosimilar to Eylea in Europe further strengthening the Companys growing biosimilars portfolio and expanding
CAS Connections brings trusted scientific data and AI to leading R&D platforms
Friday, June 05, 2026CAS a division of the American Chemical Society specializing in scientific knowledge management today announced CAS Connections a new integration framework that embeds the CAS Content Collection
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
Thursday, June 04, 2026Arcus Biosciences Inc NYSE RCUS a clinicalstage global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
Thursday, June 04, 2026Iovance Biotherapeutics Inc NASDAQ IOVA a commercial biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte TIL therapies for patients with cancer
Solid Biosciences and NanoMosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics
Wednesday, June 03, 2026Solid Biosciences Inc and NanoMosaic Inc today announced that they have entered into a comarketing agreement designed to increase visibility and access to two critical enabling technologies for gene therapy developers
